Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 12, 2009, Pages 3421-3425

  Goniewicz, Maciej L ^a,b,c   Havel, Christopher M ^a   Peng, Margaret Wilson ^a   Jacob III, Peyton ^a   Dempsey, Delia ^a   Yu, Lisa ^a   Zielinska Danch, Wioleta ^c   Koszowski, Bartosz ^c   Czogala, Jan ^c   Sobczak, Andrzej ^c   Benowitz, Neal L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG HALF LIFE; DRUG URINE LEVEL; FEMALE; HUMAN; KIDNEY CLEARANCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BIOMARKERS, PHARMACOLOGICAL; CARCINOGENS; CHROMATOGRAPHY, LIQUID; FEMALE; HALF-LIFE; HUMANS; LUNG; MALE; MIDDLE AGED; NITROSAMINES; RISK FACTORS; SMOKING; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

EID: 73349107435     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0874     Document Type: Article

References (11)

1. Benowitz NL, Hukkanen J, Jacob P, III. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 2009:29-60.
2. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996;18:188-204.
3. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002;23:907-22.
4. Hecht SS, Carmella SG, Chen M, et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res 1999;59:590-6.
5. Hecht SS, Carmella SG, Ye M, et al. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Res 2002;62:129-34.
6. Yuan JM, Koh WP, Murphy SE, et al. Urinary levels of tobaccospecific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res 2009;69: 2990-5.
7. Church TR, Anderson KE, Caporaso NE, et al. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev 2009;18:260-6.
8. Jacob P, III, Havel C, Lee DH, Yu L, Eisner MD, Benowitz NL. Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Anal Chem 2008;80:8115-21.
9. Eisner MD, Jacob P, III, Benowitz NL, Balmes J, Blanc PD. Longer term exposure to second-hand smoke and health outcomes in COPD: impact of urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Nicotine Tob Res 2009;11:945-53.
10. Roethig HJ, Munjal S, Feng S, et al. Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers. Nicotine Tob Res 2009;11:1216-25.
11. Carmella SG, Chen M, Han S, et al. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol 2009;22:734-41.